Company Long-Term Loans and Borrowings: Galapagos Genomics (GLPG)

Public company logo of Galapagos Genomics (GLPG)

Galapagos NV is implementing automated molecule screening to optimize drug discovery. The company's long-term debt changes demonstrate a recovery trend, where 0.00 describes the current status of the metric. Galapagos NV combines AI-driven drug design with robotic manufacturing. However, business success currently depends on the approval of new developments by US and EU regulators to expand the patient base.

GLPG Galapagos NV Company Long-Term Debts (07/04/2022 - 05/08/2026)

Summary analytical data breakdowns for Galapagos Genomics (GLPG)

- market price and analyst price targets:
Stock Price glpg.com|GLPG - Price Target Chart
- company stock exchange capitalization indicators:
Market Value Galapagos|GLPG - Total Company Value
- book capitalization information:
Accounting Value per Share Galapagos|GLPG - Book Capitalization|Market Capitalization to Book Value Ratio glpg.com|GLPG - Cumulative Company Assets
- debt level and financial liquidity data:
All Debt to Shareholders' Equity Ratio Galapagos NV|GLPG - Long-Term Debt to Equity|Current Liabilities to Capital Galapagos Corp|GLPG - Company Total Debt|Debt to Book Capital Galapagos|GLPG - Company Long-Term Debts|Company Short-Term Loans and Borrowings Galapagos|Immediate Liquidity glpg.com
- earnings and multiples data:
GLPG - Company Net Income
Fundamental company valuation:glpg.com GLPG
Brand item of Galapagos

Investors are verifying the issuer's financial stability by analyzing long-term liabilities to assess the business's ability to service obligations with maturities exceeding one year. The trend in long-term liabilities reflects the volume of debt capital required by Galapagos NV (GLPG) to finance the restructuring of its immunology portfolio and the development of new drugs, providing insight into the level of credit burden during this period of technological transformation.

Who Galapagos NV competes with

Company Long-Term Debts haleon.com HLN|KVUE - Company Long-Term Debt|Company Long-Term Loans and Borrowings VRNA (Verona Pharma PLC)|Jyong Biotech Corp (MENS) - Company Long-Term Debt|Company Long-Term Liabilities Ligand Corp|AMRX (Amneal Pharmaceuticals) - Company Long-Term Debts|Company Long-Term Debts perrigo.com|Company Long-Term Liabilities ALVO (Alvotech SA)|LQDA (Liquidia Corp) - Company Long-Term Loans and Borrowings|Company Long-Term Debt ANI Pharma ANIP|Afrezza (MNKD) - Long-Term Debt|AMPH: Company Long-Term Liabilities|pacira.com - Amount of Long-Term Liabilities|SPRY: Company Long-Term Debts|Theravance Biopharma Inc - Company Long-Term Loans and Borrowings|AQST (Aquestive Pharma) - Company Long-Term Debts|Long-Term Debt scPharma SCPH|Company Long-Term Debt Tectonic Therapeutic, Inc. (TECX)|TNXP (tonixpharma.com) - Company Long-Term Loans and Borrowings|Company Long-Term Debts SXTC (China SXT Pharmaceuticals, Inc.)|Long-Term Indebtedness Eupraxia Pharmaceuticals, Inc.|BioHarvest - Company Long-Term Debts|EXOZ - Company Long-Term Debts|oramed.com (ORMP) - Company Long-Term Debt|ENTX (Entera Bio) - Company Long-Term Debt|HYFT (MindWalk Holdings Inc.) - Company Long-Term Debts|Company Long-Term Debts ABVC BioPharma Inc.|Company Long-Term Debt Cumberland Pharma (CPIX)|QNTM: Long-Term Liabilities|Company Long-Term Debts FGEN (FibroGen, Inc.)|Company Long-Term Debts telomirpharma.com TELO|Rani Therapeutics Inc - Company Long-Term Debts|Long-Term Indebtedness Synergy CHC Corp (SNYR)|rallybio.com (RLYB) - Company Long-Term Debt|Long-Term Debt Lexaria Bioscience Corp. (LEXX)|Company Long-Term Debt Pulmatrix, Inc.|Pheton (PTHL) - Long-Term Debt Volume|Company Long-Term Liabilities APM (Aptorum Group Limited)|LYRA (Lyra Therapeutics Inc.) - Company Long-Term Loans and Borrowings|Company Long-Term Debt Impact BioMedical Inc IBO|TNFA: Company Long-Term Indebtedness|YCBD: Company Long-Term Liabilities|PRFX: Company Long-Term Debt|CYTO: Company Long-Term Debts|Long-Term Indebtedness Lipella Pharmaceuticals Inc LIPO|Company Long-Term Debt Optinose|Company Long-Term Debt PIRS|Company Long-Term Debt Procaps Group S.A. (PROC)|PTPI: Long-Term Liabilities|Company Long-Term Debts QLI (Qilian International Holding)|Long-Term Indebtedness Acelyrin Inc.|TFFP - Company Long-Term Debt